DEA Archived Press Releases

Press Releases before January 20, 2025
5 Results - Showing 1 to 5
PRESS RELEASE

Former Guinea-Bissau President’s Son Sent to U.S. prison for International Drug Trafficking

HOUSTON – The leader of a transnational drug trafficking organization has been imprisoned for his involvement in an international heroin trafficking conspiracy, announced Drug Enforcement Administration Special Agent in Charge Daniel C. Comeaux, Houston Division and U.S. Attorney Alamdar S. Hamdani. Malam Bacai Sanha Jr., 52, pleaded guilty Sept. 6...
PRESS RELEASE

Manhattan U.S. Attorney announces extradition of OFAC- sanctioned Afghan man for Narco-Terrorism offenses

NEW YORK - Christopher Tersigni, Special Agent in Charge of the United States Drug Enforcement Administration Special Operations Division and Geoffrey S. Berman, the United States Attorney for the Southern District of New York, announced today the extradition of Haji Abdul Satar Abdul Manaf, aka “Haji Abdul Sattar Barakzai,” for...
PRESS RELEASE

DEA acts against dangerous, deadly designer synthetic drug linked to 151 overdose deaths since 2015

WASHINGTON – The Drug Enforcement Administration today announced action against a dangerous designer synthetic cathinone linked to 151 overdose deaths in the United States between 2015 and 2018. Published in today’s Federal Register, DEA’s action puts N-Ethylpentylone into Schedule I of the Controlled Substances Act. Schedule I substances refer to...
PRESS RELEASE

DEA investigators seeking answers in small Tennessee town

CELINA, Tenn. -- DEA investigators this week conducted inspections at several pharmacy locations in the Clay County, Tennessee town of Celina, following an inquiry into irregular patterns of pill purchases from drug distribution companies. DEA is now investigating possible criminal activity involving the illicit diversion of controlled prescription pharmaceuticals at...
PRESS RELEASE

Justice Department, DEA propose significant opioid manufacturing reduction in 2019

WASHINGTON – The Department of Justice and U.S. Drug Enforcement Administration have proposed a reduction for controlled substances that may be manufactured in the U.S. next year. Consistent with President Trump’s “Safe Prescribing Plan” that seeks to “cut nationwide opioid prescription fills by one-third within three years,” the proposal decreases...